Form 4: Astrana Health Director Exercises Stock Options

Astrana Health Director Matthew Mazdyasni exercised 20,000 stock options, increasing his direct common stock holdings.

Summary

• Matthew Mazdyasni, a Director of Astrana Health, Inc. (ASTH), exercised 20,000 stock options on November 10, 2025.
• The exercise price for these options was $18.20 per share, totaling a transaction value of $364,000.
• Following the transaction, Mr. Mazdyasni directly beneficially owns 34,763 shares of common stock.
• This total includes 6,449 shares of restricted stock, which are set to vest on the earlier of June 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders.
• The stock options exercised were fully vested and exercisable, and the transaction occurred one day before their expiration date of November 11, 2025.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director, especially under a Rule 10b5-1 plan and increasing direct ownership, generally indicates continued confidence in the company's future prospects, contributing to a positive sentiment.

Positives

• The exercise of stock options by a director indicates continued confidence in the company's future prospects.
• The transaction increases the director's direct beneficial ownership in Astrana Health, aligning insider interests with shareholders.
• The exercise was pre-planned under a Rule 10b5-1 plan, suggesting a structured approach to insider transactions.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider transaction.

Industry Context

Insider transactions, such as option exercises that increase ownership, are often viewed by the market as a signal of management's belief in the company's future prospects, potentially indicating a positive outlook compared to peers where insiders might be selling.

Stakeholder Impact

• Shareholders may view the increased insider ownership as a positive signal, potentially boosting confidence in the company's leadership and future performance.

Next Steps

• Vesting of 6,449 shares of restricted stock on the earlier of June 11, 2026, or the date of the Issuer's 2026 annual meeting of stockholders.

Key Dates

Recommendation

The exercise of stock options by a director, particularly when it increases their direct ownership and is executed under a pre-planned 10b5-1 program, generally signals insider confidence in the company's long-term value. While not a strong 'buy' signal on its own, it suggests that current holders should maintain their positions, as management's interests are further aligned with shareholders.

Keywords

Astrana Health, ASTH, Stock Options, Insider Transaction, Form 4, Director, Equity, Rule 10b5-1